As of 2026-03-21, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.32 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.05 CAD, the upside of Revive Therapeutics Ltd is -738.76%.
Based on its market price of 0.05 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 738.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.32 - -0.32 | -0.32 | -738.76% |
| P/E | (1.06) - (1.52) | (1.29) | -2687.0% |
| DDM - Stable | (0.70) - (3.29) | (2.00) | -4095.6% |
| DDM - Multi | (0.01) - (0.04) | (0.02) | -136.4% |
| Market Cap (mil) | 8.37 |
| Beta | -6.43 |
| Outstanding shares (mil) | 167.43 |
| Enterprise Value (mil) | 8.43 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.06% |
| Cost of Debt | 5.00% |
| WACC | 8.02% |